ArticleActa dermato-venereologica2026

OX40/OX40L Inhibitors in Atopic Dermatitis: Current Evidence on Short-term Safety.

Kian Karimian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.